PT - JOURNAL ARTICLE AU - Wu, Xiaomin AU - Wang, Zengmiao AU - He, Zhenyu AU - Li, Yapin AU - Wu, Yating AU - Wang, Huaiji AU - Liu, Yonghong AU - Hao, Fanghua AU - Tian, Huaiyu TI - A follow-up study shows no new infections caused by patients with repeat positive of COVID-19 in Wuhan AID - 10.1101/2020.11.18.20232892 DP - 2020 Jan 01 TA - medRxiv PG - 2020.11.18.20232892 4099 - http://medrxiv.org/content/early/2020/11/21/2020.11.18.20232892.short 4100 - http://medrxiv.org/content/early/2020/11/21/2020.11.18.20232892.full AB - Background It has been reported that a few recovered COVID-19 patients could suffer repeat positive, testing positive for the SARS-CoV-2 virus again after they were discharged from hospital. Understanding the epidemiological characteristics of patients with repeat positive is vital in preventing a second wave of COVID-19.Methods In this study, the epidemiological and clinical features for 20,280 COVID-19 patients from multiple centers between 31 December 2019 and 4 August 2020 in Wuhan were collected and followed. In addition, the RT-qPCR testing results for 4,079 individuals who had close contact with the patients suffering repeat positive were also obtained.Results 2,466 (12.16%) of 20,280 patients presented with a repeat positive of SARS-CoV-2 after they were discharged from hospital. 4,079 individuals had close contact with them. The PCR result were negative for the 4,079 individuals.Conclusions By a follow-up study in Wuhan, we show the basic characteristics of patients with repeat positive and no new infections caused by patients with repeat positive of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Major Prevention Projects of Hubei Province Health Committee (WJ2019H303); Beijing Natural Science Foundation (JQ18025); Beijing Advanced Innovation Program for Land Surface Science; National Natural Science Foundation of China (81673234); Young Elite Scientist Sponsorship Program by CAST (YESS)(2018QNRC001). HT acknowledge support from the Oxford Martin School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The epidemiological and clinical data collection was exempt from Institutional Review Boards because it was part of public health investigation for COVID-19, issued by the National Health Commission of the People's Republic of China (http://www.nhc.gov.cn/jkj/s3577/202003/4856d5b0458141fa9f376853224d41d7.shtml). This study was approved by the Institutional Review Boards from the Wuhan Center for Disease Control and Prevention.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data supporting the findings of this study are available within the article.Term definitionPatient with repeat positivethe patient was test positive for SARS-CoV-2 again after being discharged from hospital.Treatment timetime interval of a patient being hospitalized.Close contactthe individuals living in the same houses with the patients.